Adrenergic receptor knockout mice: Distinct functions of 9 receptor subtypes

Pharmacology and Therapeutics

Volumn 101, Issue 1, 2004, Pages 65-74

  Philipp, Melanie ^a,b   Hein, Lutz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adrenergic receptors; G protein coupled receptors; Genetically altered mice; Receptor signaling

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1C ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 4 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CONCANAVALIN A; DOXAZOSIN; G PROTEIN COUPLED RECEPTOR; MOXONIDINE; NORADRENALIN; POTASSIUM CHANNEL; POTASSIUM ION; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADRENAL GLAND; BLOOD PRESSURE; CARDIOMYOPATHY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; DRUG EFFECT; EMBRYO DEVELOPMENT; ENDOCYTOSIS; GENE DELETION; GENE OVEREXPRESSION; GENE TARGETING; GRAND MAL EPILEPSY; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KNOCKOUT MOUSE; METABOLIC REGULATION; NEPHRECTOMY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; TRANSGENIC ANIMAL;

EID: 0346687568     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2003.10.004     Document Type: Review

References (89)

1. ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 283:2000;1967-1975.
2. 1- adrenergic receptor-mediated regulation of β-adrenergic signaling. J Biol Chem. 272:1997;21253-21259.
3. 2A-adrenergic receptor knockout mice. Mol Pharmacol. 56:1999;154-161.
4. Bachman E.S., Dhillon H., Zhang C.Y., Cinti S., Bianco A.C., Kobilka B.K., Lowell B.B. βAR signaling required for diet-induced thermogenesis and obesity resistance. Science. 297:2002;843-845.
5. 2-adrenoceptor subtypes prevents progression of heart failure. Circulation. 106:2002;2491-2496.
6. 2 adrenergic receptor subtypes. Mol Endocrinol. 17:2003;1640-1645.
7. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R., Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 46:1994;121-136.
8. Bylund D.B., Bond R.A., Clarke D.E., Eikenburg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R., Strosberg A.D., Trendelenburg U.G. Adrenoceptors. The IUPHAR Compendium of Receptor Characterization and Classification. 1998;58-74 IUPHAR, London.
9. 2-adrenergic receptor. Nature. 401:1999;286-290.
10. 1B-adrenergic receptor. Proc Natl Acad Sci USA. 94:1997;11589-11594.
11. 2 adrenergic receptor gene. J Biol Chem. 274:1999;16694-16700.
12. 2-adrenergic receptors. Mol Pharmacol. 60:2001;955-962.
13. 2A/D-adrenoceptor knockout mice. Br J Pharmacol. 136:2002;857-864.
14. 1B-adrenoceptors in mouse. Physiol Genom. 9:2002;85-91.
15. 2 adrenoceptor knockout mice. Mol Pharmacol. 60:2001;577-583.
16. 1B-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci. 22:2002;2873-2884.
17. Dubocovich M.L., Langer S.Z. Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors. J Physiol. 237:1974;505-519.
18. 1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA. 96:1999;7059-7064.
19. 2-adrenergic receptor subtypes in human placenta: evidence from direct binding studies. Placenta. 15:1994;661-668.
20. Falkay G., Melis K., Kovacs L. Correlation between β- and α-adrenergic receptor concentrations in human placenta. J Recept Res. 14:1994;187-195.
21. 2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J Neurosci. 22:2002;8771-8777.
22. 1-adrenergic blockade. Circulation. 107:2003;127-131.
23. 12B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am J Physiol. 275:1998;H1338-H1350.
24. 2C adrenoceptor subtypes in mice. Anesthesiology. 90:1999;470-476.
25. Hall R.A., Lefkowitz R.J. Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ Res. 91:2002;672-680.
26. + exchange. Nature. 392:1998;626-630.
27. 2-adrenergic receptor subtype function. Rev Physiol Biochem Pharmacol. 142:2001;161-185.
28. 1-Adrenoceptors in the heart: friend or foe? J Mol Cell Cardiol. 35:2003;1183-1185.
29. 2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 402:1999;181-184.
30. 3H] rauwolscine. Neuroscience. 117:2003;875-898.
31. 2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol. 122:1997;1339-1344.
32. 4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's Arch Pharmacol. 363:2001;87-93.
33. 2A adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice. Pain. 85:2000;345-358.
34. Koch W.J., Lefkowitz R.J., Rockman H.A. Functional consequences of altering myocardial adrenergic receptor signaling. Annu Rev Physiol. 62:2000;237-260.
35. 3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol. 57:2000;252-258.
36. 1-adrenoceptor pharmacology. Pharmacol Ther. 98:2003;235-244.
37. 2A-adrenergic receptor knockout mice. Neuroscience. 113:2002;289-299.
38. 2A-adrenoceptor subtype. Neuropharmacology. 44:2003;882-892.
39. 2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception. Eur J Pharmacol. 468:2003;183-189.
40. 2A-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA. 94:1997;9950-9955.
41. AR activity via molecular crosstalk. J Mol Cell Cardiol. 30:1998;1827-1839.
42. 1B-adrenergic receptor induces dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 281:2001;H931-H938.
43. 2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation. 101:2000;1707-1714.
44. 2C-adrenoceptor homolog. Mol Pharmacol. 48:1995;48-55.
45. 2-adrenergic receptor subtypes b and c. Science. 273:1996;803-805.
46. 2A-adrenergic receptor subtype. Science. 273:1996;801-803.
47. 2 receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine. Br J Pharmacol. 132:2001;1827-1836.
48. 1B-adrenoceptor double knockout mice. J Mol Cell Cardiol. 35:2003;1207-1216.
49. 1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest. 111:2003;1783-1791.
50. 2A- Adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus. Hypertension. 41:2003;571-575.
51. 2-adrenoceptors control vascular development at the interface between mother and embryo. Nat Genet. 31:2002;311-315.
52. 2-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol. 283:2002;R287-R295.
53. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 3:2002;639-650.
54. 3-adrenoceptor in the regulation of body composition. J Clin Invest. 100:1997;1098-1106.
55. Rohrer D.K. Targeted disruption of adrenergic receptor genes. Methods Mol Biol. 126:2000;259-277.
56. Rohrer D.K., Kobilka B.K. Insights from in vivo modification of adrenergic receptor gene expression. Annu Rev Pharmacol Toxicol. 38:1998;351-373.
57. 1-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci USA. 93:1996;7375-7380.
58. 2-adrenergic receptors. J Biol Chem. 274:1999;16701-16708.
59. 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA. 99:2002;9474-9479.
60. 2B adrenoceptors. J Neurosci. 20:2000;9242-9251.
61. 2C-adrenoceptor as a neuropsychiatric drug target studies in transgenic mouse models. Life Sci. 68:2001;2277-2285.
62. Simpson P.C., Kariya K., Karns L.R., Long C.S., Karliner J.S. Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem. 104:1991;35-43.
63. 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem. 275:2000;23059-23064.
64. Small K.M., Rathz D.A., Liggett S.B. Identification of adrenergic receptor polymorphisms. Methods Enzymol. 343:2002;459-475.
65. 2C- adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 347:2002;1135-1142.
66. Small K.M., McGraw D.W., Liggett S.B. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol. 43:2003;381-411.
67. 2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol. 37:2001;1516-1522.
68. 2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J Am Coll Cardiol. 41:2003;190-194.
69. 1B-adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities. Neurobiol Learn Mem. 75:2001;214-229.
70. 2-adrenoceptors. J Neurochem. 78:2001;685-693.
71. Starke K., Montel H., Gayk W., Merker R. Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. α-sympathomimetic inhibition of neurogenic vasoconstriction. Naunyn-Schmiedeberg's Arch Pharmacol. 285:1974;133-150.
72. 1-Adrenergic receptor subtype function in cardiomyocytes: lessons from genetic models in mice. J Mol Cell Cardiol. 34:2002;1141-1145.
73. 3-adrenergic receptor gene. J Biol Chem. 270:1995;29483-29492.
74. 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc Natl Acad Sci USA. 99:2002;12471-12476.
75. 1D-adrenergic receptor in the development of salt-induced hypertension. Hypertension. 40:2002;101-106.
76. 1-adrenergic receptor subtype function. Life Sci. 71:2002;2207-2215.
77. 1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest. 109:2002;765-775.
78. 2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg's Arch Pharmacol. 356:1997;721-737.
79. 2A/D-adrenoceptor-deficient mice. Naunyn-Schmiedeberg's Arch Pharmacol. 360:1999;540-551.
80. 2C-adrenoceptor-deficient mice. Naunyn-Schmiedeberg's Arch Pharmacol. 364:2001;117-130.
81. 2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn-Schmiedeberg's Arch Pharmacol. 2003;. (published online Nov. 11, 2003).
82. 1D-AR. Am J Physiol Heart Circ Physiol. 284:2003;H1104-H1109.
83. 1B- adrenergic receptor defect in mice. Circulation. 105:2002;1700-1707.
84. Xiang Y., Kobilka B.K. Myocyte adrenoceptor signaling pathways. Science. 300:2003;1530-1532.
85. 1-adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J Biol Chem. 277:2002;33783-33790.
86. 2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem. 277:2002;34280-34286.
87. 2+/calmodulin kinase. J Clin Invest. 111:2003;617-625.
88. 1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med. 6:2000;1388-1394.
89. 1B-adrenergic receptor. J Biol Chem. 276:2001;13738-13743.